1. Explosive growth of the biologicals market

Brazil is one of the fastest-growing markets for biological agricultural inputs worldwide. The biological sector has expanded at an average annual rate of ~21% in recent years, four times higher than the global average. The Brazilian biologicals market already exceeds $1.3 billion annually and is projected to surpass $3 billion by 2030, driven by rapid adoption of sustainable agricultural technologies.

​

2. Brazil: a global agricultural powerhouse

Brazil is one of the world’s largest producers and exporters of key crops such as soybean, corn, sugarcane, and coffee, with agribusiness representing a major share of the national economy. This creates a massive and immediate demand for innovative, scalable, and sustainable agricultural technologies.

​

3. Favorable and evolving regulatory framework

Brazil has established a dedicated regulatory framework for biologicals, distinct from traditional agrochemicals. This modern approach accelerates innovation and adoption of biological technologies. Compared to human health applications, agricultural biological products benefit from faster development and approval pathways, lower regulatory barriers, and reduced clinical validation requirements, enabling significantly faster time-to-market and lower overall development costs.

 

4. The next frontier: extracellular vesicle-based biologicals

Extracellular vesicles represent a new class of biologicals, enabling precise delivery of bioactive molecules, RNA, and biological signals. EVerse is positioned at the forefront of this emerging field, combining advanced biotechnology, scalable microbial production, and precision delivery systems to create a high-impact, high-growth opportunity in a market actively seeking next-generation solutions.